Skip to main content

Balchem Corporation to Present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025

MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations, will present at the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:Jacqueline Yarmolowicz
 Balchem Corporation (Telephone: 845-326-5600)



Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  225.06
-5.25 (-2.28%)
AAPL  271.60
+1.90 (0.70%)
AMD  259.92
-4.41 (-1.67%)
BAC  53.20
+0.62 (1.17%)
GOOG  285.48
+10.31 (3.75%)
META  677.52
-74.15 (-9.86%)
MSFT  526.64
-14.91 (-2.75%)
NVDA  202.89
-4.15 (-2.00%)
ORCL  261.30
-14.00 (-5.09%)
TSLA  445.45
-16.06 (-3.48%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.